Kim Kelderman, President Diagnostics & Genom at BIO-TECHNE Corp (TECH), sold 500 shares at $505.78 ($253K) on 2021-11-19, disclosed to the SEC on 2021-11-23.
Open-market sale of $253k TECH by President Diagnostics & Genom. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $503.76 | 100 | $50K | 19.9% |
| 2 | $505.78 | 400 | $202K | 80.1% |
| Total | $505.38 avg | 500 | $253K | 100% |
| Filing → |
| TECH | SELL | 2021-06-11 | $351K | — | Filing → |
| TECH | SELL | 2021-05-27 | $358K | — | Filing → |
| TECH | SELL | 2021-02-09 | $639K | — | Filing → |